Dual Sympathetic Blocks for Patients Experiencing Sympathetically-Mediated Symptoms From Long COVID
Status:
Recruiting
Trial end date:
2023-03-31
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to gather data and assess changes in patient-reported
outcomes with the stellate ganglion blocks as treatment for their sympathetically-mediated
long COVID symptoms.